Bruce Yergin
Pulmonary Disease · Jacksonville, FLNPI 1619962230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by GSK at 32.5% of the total. Reporting peaked in 2019 at $1,572 and has fallen 98.1% since, to $29 in 2022. That places this record below the midpoint for pulmonary disease clinicians in FL, where the typical reported total is $2,936.
Across 112 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$626
- AstraZeneca$318
- Sanofi$193
- Grifols USA, LLC$186
- Philips North America LLC$171
- Boehringer Ingelheim$93
- plus $338 from 10 others
Across 26 payments — averaging $2316.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$60K
What the payments were for
- Food & beverage$1,924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 44 | $626 |
| AstraZeneca | 14 | $318 |
| Sanofi | 5 | $193 |
| Grifols USA, LLC | 9 | $186 |
| Philips North America LLC | 13 | $171 |
| Boehringer Ingelheim | 6 | $93 |
| Sunovion Pharmaceuticals Inc. | 6 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Merck | 3 | $46 |
| Electromed, Inc. | 3 | $44 |
| Genentech USA, Inc. | 2 | $35 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,924 in reported general payments places this provider in the 40th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Jacksonville
- Jennifer FultonJacksonville$665K
- Jose Soto SotoJacksonville$504K
- Jorge MalleaJacksonville$457K
- Abubakr BajwaJacksonville$414K
- Bryan HustaJacksonville$283K
- Sebastian Fernandez-BussyJacksonville$257K
- Peter NassarJacksonville$141K
- Charles BurgerJacksonville$124K
- Daniel WyzanJacksonville$100K
- David Abia TrujilloJacksonville$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.